5th European Congress on Hematology and Blood Disorders
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 5th European Congress on Hematology and Blood Disorders — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
5th European Congress on Hematology and Blood Disorders
Event Overview: The 5th European Congress on Hematology and Blood Disorders is a premier international event dedicated to advancing the field of hematology and addressing critical issues in blood disorders. This conference brings together leading scientists, physicians, researchers, and healthcare professionals from around the world to share the latest research findings, innovative treatment strategies, and best practices in patient care.
Event Details
- Date: May 28-29, 2026
- Venue: To be announced (Please check the official website for updates)
- Location: Europe (Exact city and country to be confirmed)
Conference Highlights
This event will feature:
- Keynote speeches from renowned experts in hematology, including Androulla Eleftheriou (Thalassaemia International Federation, Cyprus), Eliza Ng (Montefiore Health System, USA), Joan-LLuis Vives Corrons (Institute for Leukaemia Research, Spain), and Xiaofeng Shi (The Second Affiliated Hospital of Nanjing Medical University, China).
- Scientific sessions covering a wide range of topics such as leukemia, lymphoma, thrombosis, hemoglobinopathies, and hematopoietic stem cell transplantation.
- Opportunities for poster and e-poster presentations, allowing researchers to showcase their work and receive feedback from peers.
- Networking sessions with professionals from academia, industry, and healthcare institutions.
- Exhibition of the latest products and services in hematology and related fields.
Target Audience
This conference is designed for:
- Hematologists
- Oncologists
- Research scientists
- Medical students and residents
- Pharmaceutical and biotechnology industry professionals
- Patient advocacy groups
Call for Abstracts
All researchers and healthcare professionals are invited to submit abstracts for consideration. Accepted abstracts will be published in Conference Series International Journals and provided with a Digital Object Identifier (DOI). The deadline and submission guidelines can be found on the official website.
Contact Information
For more information, please contact:
- Registration & Abstract Submission: meevents@memeetings.com
- Sponsors & Exhibitors: sponsor@conferenceseries.com
- General Inquiries: meevents@memeetings.com or call +44-203-318-0199
- Address: 35 Ruddlesway, Windsor, Berkshire, SL4 5SF, UK
Official Website
For the most up-to-date information, please visit the official conference website.
Data sheet
5th European Congress on Hematology and Blood Disorders – Event Attendee & Buyer Profile Analysis
Event date: May 28-29, 2026
Location: Europe; user-provided location details indicate Barcelona, Spain and Hotel Best Front Maritim, but these were not verified in the official event page excerpt
Event status: Upcoming
Research date: June 30, 2026
Event Overview
| Event Name | 5th European Congress on Hematology and Blood Disorders |
| Event Date | May 28-29, 2026 (Confirmed on official event page excerpt) |
| Event Status | Upcoming |
| Venue | Hotel Best Front Maritim (User-provided detail; not verified in the official event page excerpt) |
| City | Barcelona (User-provided detail; not verified in the official event page excerpt) |
| State / Region | Catalonia (Derived from user-provided city; not verified in the official event page excerpt) |
| Country | Spain (User-provided detail; official excerpt places the event in Europe and lists Spain among destinations, but does not explicitly confirm Barcelona as host city) |
| Organizer | Conference Series |
| Official Event Website | hematology.conferenceseries.com/europe/ |
| Event Type | Medical conference / scientific congress with speaker, abstract, poster, sponsor, and exhibitor opportunities |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research |
| Audience Reach | Global |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for volume metrics; organizer confirms event existence, dates, speaker opportunities, poster opportunities, and sponsor/exhibitor participation, but not attendee totals in the provided excerpt |
| Main Purpose of Event | To convene hematology researchers, clinicians, medical leaders, and related industry participants for scientific exchange, clinical updates, research presentation, partnerships, and visibility among blood-disorder specialists. |
About the Event
The 5th European Congress on Hematology and Blood Disorders is positioned as a specialist medical and scientific conference focused on hematology, blood disorders, and adjacent clinical and translational research topics. The official event page confirms a 2026 edition under Conference Series, with speaker, poster, e-poster, sponsor, and exhibitor participation pathways. The visible speaker lineup includes organizations from Cyprus, Spain, China, and the United States, indicating cross-border scientific participation.
For commercial and lead-generation purposes, this event is most relevant for organizations selling into hospitals, academic medicine, diagnostic laboratories, transfusion medicine, rare-disease care, clinical research, and hematology-focused pharma or biotech ecosystems. Buyer activity is likely to be influence-led rather than classic procurement-floor buying; this means the strongest value is access to medical decision-makers, research collaborators, scientific KOL environments, and healthcare partnership opportunities rather than mass transactional purchasing.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Hematologists and clinical specialists | Hospitals, academic medical centers, specialty clinics | High clinical influence over diagnostics, therapies, devices, and treatment protocols | Core audience for clinical education, product awareness, referral networks, and therapy adoption |
| Clinical researchers and principal investigators | Research institutes, universities, hospital research units | Influence clinical trial participation, publication visibility, biomarker use, and research collaborations | Relevant for CROs, lab suppliers, trial-tech vendors, sample management, and research partnerships |
| Hospital department leaders | Cancer centers, transfusion departments, pathology labs, hematology units | Budget and specification influence for equipment, lab services, software, and care pathways | Strong for enterprise sales, departmental pilots, and long-cycle procurement |
| Pharma and biotech medical affairs teams | Pharmaceuticals, biotechnology, rare-disease firms | Scientific engagement, investigator relations, education partnerships, KOL outreach | Important for co-marketing, symposiums, clinical education, and partnership development |
| Diagnostic and laboratory leaders | Clinical laboratories, molecular diagnostics groups, blood banks | Specify assays, instruments, reagents, workflow systems, and validation projects | High relevance for diagnostics, sample prep, lab software, and quality systems suppliers |
| Patient advocacy and disease-foundation leaders | Disease federations, nonprofit associations | Influence awareness, policy dialogue, education, and patient-network partnerships | Useful for outreach programs, awareness campaigns, and community engagement |
| Sponsors and exhibitors | Medical suppliers, publishers, healthcare service providers | Commercial participants seeking demand generation and scientific visibility | Relevant for partnership, channel, and cross-sell opportunities |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city | Barcelona (user-provided, not verified in official page excerpt) | Likely concentration of regional hospitals, universities, and medical research institutions | Location-based prospecting should be used cautiously until city is formally confirmed on the organizer page |
| Host state / region | Catalonia | Strong life-sciences and healthcare ecosystem if Barcelona hosting detail is accurate | Derived from user-provided city detail, not confirmed by organizer excerpt |
| Nearby business hubs | Madrid, Valencia, Toulouse, Southern Europe medical corridors | Moderate to high for healthcare, diagnostics, and research institutions | Likely draw region for a European specialist congress |
| National reach | Spain-wide medical and academic audience likely | High in hematology units, hospitals, and research centers | Supported by Spanish speaker organization listed on the event page |
| International reach | Europe, North America, Asia | High among scientific and medical participants | Confirmed by visible speaker affiliations from Cyprus, USA, Spain, and China |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The event page presents international speaker participation and is hosted by a global conference organizer with multi-region conference marketing. |
| European specialist reach | Secondary descriptor | The event branding is explicitly European and likely concentrates hematology stakeholders from Europe while still attracting non-European speakers and researchers. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Thalassaemia International Federation | Patient advocacy / international health organization | Relevant for blood-disorder awareness, clinical networks, partnerships, and education initiatives | thalassaemia.org.cy | President, Executive Director, Program Director, Partnerships Director, Medical Affairs Lead | Confirmed Speaker Organization |
| Montefiore Health System | Hospital / health system | Represents clinical leadership and potential demand for hematology care tools, diagnostics, and hospital partnerships | montefiore.org | Senior Medical Director, Hematology Director, Clinical Operations Director, Research Director | Confirmed Speaker Organization |
| Institute for Leukaemia Research Josep Carreras | Research institute | High relevance for leukemia research collaboration, translational medicine, scientific equipment, and research services | carrerasresearch.org | Research Director, Principal Investigator, Laboratory Director, Scientific Partnerships Lead | Confirmed Speaker Organization |
| The Second Affiliated Hospital of Nanjing Medical University | Teaching hospital / academic medical center | Relevant for hematology practice, clinical research, and international medical collaboration | jsnydefy.com | Department Chair, Hematology Specialist, Clinical Research Lead, Hospital Partnerships Manager | Confirmed Speaker Organization |
Current-year buyer organization disclosure is limited in the provided official materials. The table above therefore focuses on confirmed speaker organizations only and should not be treated as a complete current-year attendee list.
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Director of Hematology | Clinical / Medical | Director | Key clinical authority for treatment pathways, departmental priorities, and vendor evaluation |
| 2 | Senior Medical Director | Medical Affairs / Clinical Leadership | Director / Senior Director | Influences clinical partnerships, evidence review, and therapy adoption |
| 3 | Principal Investigator | Research | Manager / Director | Critical for trials, translational research, and adoption of research tools or services |
| 4 | Laboratory Director | Laboratory / Diagnostics | Director | Owns evaluation of testing workflows, instrumentation, reagent use, and lab operations |
| 5 | Clinical Research Director | Research / Clinical Trials | Director | Relevant for CROs, trial technology, sample logistics, and data services |
| 6 | Medical Affairs Director | Medical Affairs | Director | High-value role at pharma and biotech organizations engaging with KOLs and evidence dissemination |
| 7 | Procurement Manager | Procurement / Supply Chain | Manager | Relevant where hospital, lab, or research institute purchasing cycles are active |
| 8 | Partnerships Director | Business Development / Partnerships | Director | Valuable for collaborations, sponsorships, programs, and nonprofit-health system alliances |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core clinical buyer environment for hematology treatment and blood disorder care | Clinical solutions, diagnostics, services, software, and patient-care partnerships |
| 2 | Research | The event is research-heavy and supports abstract and poster participation | Research collaborations, lab workflows, and scientific services |
| 3 | Pharmaceuticals | Hematology and blood disorders are major therapy and education areas for pharma | Medical affairs, KOL engagement, disease education, therapy-market access support |
| 4 | Biotechnology | High relevance for cell therapy, precision medicine, biomarkers, and blood-disorder innovation | Scientific collaborations, trial support, biomarker and assay adoption |
| 5 | Medical Devices | Applicable for hematology diagnostics, laboratory instrumentation, and patient monitoring | Instrumentation and device evaluation |
| 6 | Medical Practice | Captures specialist clinics and physician-led practice groups | Specialist engagement and referral-network development |
| 7 | Higher Education | University medical faculties and academic collaborators are likely participants | Research partnerships and education programs |
| 8 | Nonprofit Organization Management | Relevant for disease foundations and patient advocacy bodies | Awareness partnerships, grants, patient engagement, advocacy initiatives |
| 9 | Health, Wellness & Fitness | Useful for supportive care, survivorship, and patient support ecosystems | Patient engagement and holistic care services |
| 10 | Information Technology & Services | Relevant where clinical data, research informatics, and digital trial support are in scope | Clinical data systems, registry tools, analytics, research platforms |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Not confirmed | Official event page excerpt reviewed | No attendee total stated in the provided official content |
| Exhibitor count | Not publicly confirmed | Not confirmed | Official event page excerpt reviewed | Exhibitor opportunity is mentioned, but count is not disclosed |
| Buyer count | Not publicly confirmed | Not confirmed | Official event page excerpt reviewed | Medical congresses usually emphasize scientific attendees rather than formal hosted buyers |
| Speaker count | At least 4 visible speaker organizations | Partially confirmed | Official event page excerpt speaker section | Only visible speaker records in the provided excerpt were counted |
| Sponsor count | Not publicly confirmed | Not confirmed | Official event page excerpt reviewed | Sponsor contact path exists, but counts are not shown |
| Historical attendance | Not available from provided materials | Historical / prior-year evidence unavailable | Provided source set only | A past conference report link is referenced on the official page, but detailed metrics were not included in the supplied source text |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Hematology clinical practice | Updated treatment knowledge, case exchange, protocol improvement | Clinical education, advisory meetings, KOL networking | Therapeutic solutions, CME support, decision-support tools |
| Blood disorders and rare disease management | Specialist care pathways, patient management, advocacy coordination | Foundation partnerships and disease-awareness programs | Patient support services, nonprofit collaboration, specialty care tools |
| Leukemia research | Trial collaboration, translational research support, biomarker capabilities | Research partnership meetings and investigator engagement | Lab services, assay platforms, clinical trial support |
| Diagnostics and laboratory workflows | Test accuracy, throughput, data handling, workflow efficiency | Hands-on product discussions and departmental demos | Analyzers, reagents, LIMS, sample prep, automation tools |
| Scientific publishing and abstract visibility | Visibility for findings, DOI-linked abstracts, broader dissemination | Author outreach, publication services, education products | Publishing support, scientific communications, event media services |
| Industry sponsorship and exhibition | Brand visibility, direct clinician access, scientific credibility | Booth presence, sponsored sessions, lead capture | Event marketing, sponsorship packages, account-based follow-up |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | Strong for healthcare, diagnostics, research, and medical education suppliers targeting hematology stakeholders. |
| Decision-maker availability | Medium | Medical congresses provide access to influential clinicians and researchers, but formal procurement teams may be less visible than at sourcing expos. |
| Data collection potential | Medium | Attendee-scale data was not publicly disclosed in the provided materials; list-building opportunity depends on exhibitor participation, speaker tracking, and post-event enrichment. |
| Apollo targeting potential | High | Hospitals, research institutes, pharma, biotech, and nonprofit health organizations can be targeted effectively using industry and title filters. |
| Geographic targeting potential | Medium | International signal is strong, but host city and venue should be reconfirmed from the live official event page before hyperlocal outreach. |
| Best outreach approach | High | Use thought-leadership outreach, scientific relevance messaging, partnership framing, and role-specific value propositions rather than generic sales copy. |
| Overall lead quality | High | Strong event for specialized healthcare and research selling, especially where the client offering serves hematology workflows or scientific collaboration. |
| Best use case | High | Ideal for targeted ABM, speaker-organization prospecting, KOL mapping, partnership outreach, and healthcare account intelligence. |
| Limitations / risks | Medium | Public attendee volume, exhibitor lists, and formal buyer rosters were not available in the provided official content. This reduces certainty for attendee-list style sales claims. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Research; Pharmaceuticals; Biotechnology; Medical Devices; Medical Practice; Higher Education; Nonprofit Organization Management; Information Technology & Services | Build the most relevant hematology and blood-disorder buying universe |
| Departments | Medical; Research; Clinical Operations; Laboratory; Procurement; Business Development; Partnerships; Medical Affairs | Capture both clinical influencers and commercial or operational stakeholders |
| Seniority | Director; VP; CXO; Head; Manager; Partner | Prioritize people with departmental influence or partnership authority |
| Job titles | Director of Hematology; Hematologist; Senior Medical Director; Medical Director; Principal Investigator; Research Director; Laboratory Director; Clinical Research Director; Medical Affairs Director; Partnerships Director; Procurement Manager | Focus outreach on high-fit clinical and commercial decision makers |
| Geography | Spain; Cyprus; United States; China; broader Europe | Reflect current speaker footprint and probable event audience corridors |
| Employee size | 51-200; 201-500; 501-1,000; 1,001-5,000; 5,001+ | Capture specialty institutes as well as major health systems and global life-sciences organizations |
| Keywords | hematology, leukemia, lymphoma, blood disorders, thalassaemia, transfusion, stem cell, oncology, clinical research, rare disease | Improve title and company relevance where Apollo data is broad |
| Technologies, if relevant | LIMS, clinical data systems, laboratory automation, EDC, genomics platforms | Useful for clients selling lab, trial, or data infrastructure |
| Revenue range, if relevant | Mid-market to enterprise; research institutions and hospital systems of strategic size | Prioritize organizations with budget capacity and programmatic buying needs |
| Company type | Hospitals; academic medical centers; research institutes; pharma companies; biotech firms; nonprofit health associations | Align list building with actual event stakeholder types |
Suggested Apollo Search Logic: ("hematology" OR "blood disorders" OR leukemia OR lymphoma OR thalassaemia OR transfusion OR "stem cell") AND (Director OR "Medical Director" OR Hematologist OR "Principal Investigator" OR "Research Director" OR "Laboratory Director" OR "Medical Affairs Director") within Hospital & Health Care, Research, Pharmaceuticals, Biotechnology, and Medical Devices across Spain and broader Europe, with secondary expansion to speaker-origin countries.
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Conference Series Hematology Europe 2026 official page | Official event website | Organizer identity, 2026 event existence, official date May 28-29, 2026, speaker names, sponsor and exhibitor opportunity, poster and registration links | High |
| Conference Series home page | Organizer website | Organizer brand and international event portfolio context | High |
| Thalassaemia International Federation | Organization website | Organization identity and sector relevance of confirmed speaker affiliation | High |
| Montefiore Health System | Organization website | Organization identity and sector relevance of confirmed speaker affiliation | High |
| Josep Carreras Leukaemia Research Institute | Organization website | Organization identity and research relevance of confirmed speaker affiliation | High |
| The Second Affiliated Hospital of Nanjing Medical University | Organization website | Organization identity and medical-center relevance of confirmed speaker affiliation | Medium |
| User-provided event details | Secondary input | Barcelona, Spain; Hotel Best Front Maritim; October 22-23, 2026 provided by user | Low where conflicting with official page; the official source was prioritized for date, and user-provided city/venue were retained only as unverified notes |
Verification note: The official event page excerpt confirms the event date as May 28-29, 2026. The supplied Barcelona venue/date details were not visible in the provided official source text and therefore were not treated as fully confirmed. This event is suitable for specialized B2B attendee intelligence and Apollo.io account targeting, but not for claiming a verified attendee list or attendance volume based on the current public evidence provided.
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 5th European Congress on Hematology and Blood Disorders — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds